Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2011-08-30
2011-08-30
Crouch, Deborah (Department: 1632)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093100, C514S04400A, C435S320100
Reexamination Certificate
active
08007780
ABSTRACT:
Methods of making and using recombinant AAV vectors and virions for gene delivery to the lung are described. The recombinant AAV virions are derived from caprine AAV and bovine AAV, both of which display tropism for lung tissue.
REFERENCES:
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 6001650 (1999-12-01), Colosi
patent: 6004797 (1999-12-01), Colosi
patent: 6156303 (2000-12-01), Russell et al.
patent: 6376237 (2002-04-01), Colosi
patent: 2007/0072282 (2007-03-01), Chiorini et al.
Driskell and Engelhardt, An Rev Physiol 65:585-612, 2003.
Gautam et al. Am J Respir Med 1(1):35-46, 2002.
Auricchio, et al., “Noninvasive Gene Transfer to the Lung for Systematic Delivery of Therapeutic Proteins,”J Clin Invest110(4):499-504 (2002).
Balls, et al., “Transduction of Well-Differentiated Airway Epithelium by Recombinant Adeno-Associated Virus is Limited by Vector Entry,”J Virol73(7):6085-6088 (1999).
Beck, et al., “Repeated Delivery of Adeno-Associated Virus Vectors to the Rabbit Airway,”J Virol73(11):9446-9455 (1999).
(Bovine or Cow or Cattle) VP1 Entrez Sequence Search, 5 Pages, printout dated Jun. 3, 2006.
(Caprine of Goat) AAV Entrez Sequence Search, 3 Pages, printout dated Jun. 3, 2006.
Chirioni, et al., “Cloning and Characterization of Adeno-Associated Virus Type 5,”J Virol73(2):1309-1319 (1999).
De, et al., “Intrapleural Administration of a Serotype 5 Adeno-Associated Virus Coding for a 1-Antitrypsin Mediates Persistant, High Lung Serum Levels of a 1-Antitrypsin,”Mol Ther10(6):1003-1010 (2004).
Fischer, et al., “Succesful Transgene Expression with Serial Doses of Aerosolized rAAV2 Vectors in Rhesus Macaques,”Mol Ther8(6):918-926 (2003).
Flotte, et al., “Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study,”Hum Gene Ther14(11):1079-1088 (2003).
Flotte, et al., “Recent Developments in Recombinant AAV-Mediated Gene Therapy for Lung Diseases,”Curr Gene Therapy5:361-366 (2005).
Gao, et al., “Novel Adeno-Associated Viruses from Rhesus Monkeys as Vectors for Human Gene Therapy,” PNAS 99(18):11854-11859 (2002).
Goncz, et al., “Expression of DeltaF508 CFTR in Normal Mouse Lung After Site-Specific Modification of CFTR Sequences by SFHR,”Gene Ther8(12):961-965, 2001.
Grimm, et al., “Preclinical In Vivo Evaluation of Pseudotyped Adeno-Associated Virus Vectors for Liver Gene Therapy,”Blood102(7):2412-2419 (2003).
Halbert, et al., “Repeat Transduction in the Mouse Lung by Using Adeno-Associated Virus Vectors with Different Serotypes,” J Virol 74(3):1524-1532 (2000).
Halbert, et al., “Adeno-Associated Virus Type 6 (AAV6) Vectors Mediate Efficient Transduction of Airway Epithelial Cells in Mouse Lungs Compared too . . . ,” J Virol 75(14):6615-6624 (2001).
Heid, et al., “Real time Quantitative PCR,”Genome Res6(10):986-994 (1996).
Holfland, et al., “In Vivo Gene Transfer by Intraveneous Administration of Stable Cationic Lipid/DNA Complex,” Pharm Res 14(6):742-749 (1997).
Matsushita, et al., “Adeno-Associated Virus Vectors can be Efficiently Produced Without Helper Virus,”Gene Ther5(7):938-945 (1998).
Miao, et al., “Inclusion of the Hepatic Locus Control Region, an Intron, and Untranslated Region Increases ans Stabilizes Hepatic Factor IX Gene Expression In Vivo but Not In Vitro,”Mol Ther1(6):522-532 (2000).
Miao, et al., “High-Level Factor VIII Gene Expression In Vivo Achieved by NonViral Liver-Specific Gene Therapy Vectors,”Hum Gene Ther14(14):1297-1305 (2003).
Rutledge, et al., “Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other the AAV Types 2,”J Virol72(1):309-319 (1998).
Schmidt, et al., “Cloning and Characterization of a Bovine Adeno-Associated Virus,”J Virol78(12):6509-6516 (2004).
Sommer, et al., “Quantification of Adeno-Associated Virus Particles and Empty Capsids by Optical Density Measurement,”Mol Ther7(1):122-128 (2003).
Walter, et al., “Successful Expression of Human Factor IX Following Repeat Administration of Adenoviral Vector in Mice,”PNAS93(7):3056-3061 (1996).
Wilson, et al., “Gene Therapy for Cystic Fibrosis: Challenges and Future Directions,”J Clin Invest96(6):2547-2554 (1995).
Arbetman Alejandra E.
Lochrie Michael A.
Crouch Deborah
Genzyme Corporation
Noble Marcia S
Robins & Pasternak LLP
LandOfFree
AAV vectors for gene delivery to the lung does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with AAV vectors for gene delivery to the lung, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AAV vectors for gene delivery to the lung will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2658206